PolyPid Ownership
| PYPD Stock | USD 3.34 0.12 3.47% |
Shares in Circulation | First Issued 2017-09-30 | Previous Quarter 5 M | Current Value 6.4 M | Avarage Shares Outstanding 1.3 M | Quarterly Volatility 1.6 M |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
PolyPid |
PolyPid Stock Ownership Analysis
About 24.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 7.22. PolyPid had not issued any dividends in recent years. The entity had 1:30 split on the 21st of September 2023. PolyPid Ltd., a late-stage biopharma company, develops, manufactures, and commercializes products based on polymer-lipid encapsulation matrix platform to address unmet medical needs. PolyPid Ltd. was incorporated in 2008 and is headquartered in Petah Tikva, Israel. Polypid operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 75 people. To find out more about PolyPid contact the company at 972 7 4719 5700 or learn more at https://www.polypid.com.Besides selling stocks to institutional investors, PolyPid also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different PolyPid's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align PolyPid's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
PolyPid Quarterly Liabilities And Stockholders Equity |
|
About 24.0% of PolyPid are currently held by insiders. Unlike PolyPid's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against PolyPid's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of PolyPid's insider trades
PolyPid Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as PolyPid is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading PolyPid backward and forwards among themselves. PolyPid's institutional investor refers to the entity that pools money to purchase PolyPid's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Aigh Capital Management, Llc | 2024-09-30 | 679.7 K | Rosalind Advisors, Inc. | 2024-09-30 | 679.2 K | Dafna Capital Management Llc | 2024-09-30 | 308.5 K | Adar1 Capital Management Llc | 2024-09-30 | 93.9 K | Yelin Lapidot Holdings Management Ltd | 2024-06-30 | 11.2 K | Steward Partners Investment Advisory, Llc | 2024-06-30 | 7.3 K | Ubs Group Ag | 2024-06-30 | 2.4 K | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 1.8 K | Advisor Group Holdings, Inc. | 2024-06-30 | 467 | Golden State Equity Partners | 2024-09-30 | 90.0 |
PolyPid Outstanding Bonds
PolyPid issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. PolyPid uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most PolyPid bonds can be classified according to their maturity, which is the date when PolyPid has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| International Game Technology Corp BondUS460599AD57 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View |
PolyPid Corporate Filings
6K | 29th of November 2024 A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges. | ViewVerify |
13A | 28th of October 2024 An amended filing to the original Schedule 13G | ViewVerify |
| 30th of August 2024 Other Reports | ViewVerify | |
| 12th of August 2024 Other Reports | ViewVerify |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether PolyPid is a strong investment it is important to analyze PolyPid's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact PolyPid's future performance. For an informed investment choice regarding PolyPid Stock, refer to the following important reports:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PolyPid. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. For information on how to trade PolyPid Stock refer to our How to Trade PolyPid Stock guide.You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of PolyPid. If investors know PolyPid will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about PolyPid listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (7.22) | Return On Assets (0.65) | Return On Equity (4.97) |
The market value of PolyPid is measured differently than its book value, which is the value of PolyPid that is recorded on the company's balance sheet. Investors also form their own opinion of PolyPid's value that differs from its market value or its book value, called intrinsic value, which is PolyPid's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because PolyPid's market value can be influenced by many factors that don't directly affect PolyPid's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between PolyPid's value and its price as these two are different measures arrived at by different means. Investors typically determine if PolyPid is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, PolyPid's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.